Roflumilast Tablet
Product Images NDC 60687-786

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 60687-786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 Mcg Roflumilast Tablet Blister (500 Mcg Roflumilast Tablet Blister)

FDA Label Image

500 Mcg Roflumilast Tablets Carton (500 Mcg Roflumilast Tablets Carton)

500 Mcg Roflumilast Tablets Carton (500 Mcg Roflumilast Tablets Carton)
Not available*
FDA Label Image

Ahp78621

FDA Label Image

Structural Formula (Structure 01)

FDA Label Image

Figure 1. Effect Of Concomitant Drugs On The Exposure Of Roflumilast And Roflumilast N-oxide. (Figure1)

Figure 1. Effect Of Concomitant Drugs On The Exposure Of Roflumilast And Roflumilast N-oxide. (Figure1)
The text provided contains information about the change in pharmacokinetics of several drugs and their interactions. It mentions drugs like Cimetidine, Enoxacin, Fluvoxamine, Minutet, Erythromyein, Budasonide, Digoxin, Formoterol, Mastox, Midazolam, Montalukast, Saibutamot, and Ritampicin. The text also includes measurements of Cmax (maximum concentration) and AUC (area under the concentration-time curve) with their confidence intervals. The information suggests that caution should be exercised while using these drugs together, and no dose adjustment is recommended.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.